1. The determination of aldosterone-18-glucuronide (pH 1-labile aldosterone) was complemented by concomitant measurements of free urinary aldosterone and tetrahydroaldosterone in 307 patients, most of whom were hypertensive. In 38 cases ( 12.3%) the normal, aldosterone-18-glucuronide concentration was clinically misleading, but increased free aldosterone and/or tetrahydroaldosterone values suggested the presence of hyperaldosteronism, which in many of these cases was confirmed by elevated excretion of the possible mqjor aldosterone precursor 18-hydroxycorticosterone (18-OH-B).
Introduction
The determination of urinary aldosterone-18-glucuronide (pH 1-labile aldosterone) has long been the major diagnostic tool in the disorders of aldosterone secretion. With the introduction of specific and sensitive radioimmunoassay techniques for aldosterone (Mays, Furuyama, Kem & Nugent, 1970) , plasma aldosterone determinations were improved and also simplified. The use of plasma aldosterone determinations instead of urinary aldosterone-18-glucuronide has been preferred by several laboratories. However, many clinical departments, including ours, still consider the urinary determinations as the first diagnostic method because of the fluctuations of plasma aldosterone concentrations.
Two other urinary aldosterone determinations, that of unmetabolized ('free') aldosterone, and that of the major aldosterone metabolite tetrahydroaldosterone, were rarely used. In a limited number of patients, the radioimmunoassay of free aldosterone was not more useful than the determination of aldosterone-18-glucuronide (Vecsei, Penke & Joumaah, 1972; Deck, Champoin & Conn, 1973) . Radioimmunoassays of the tetrahydroaldosterone have been described more recently (Vecsei, Kohl, Mok, Pallai, Penke, Vielhauer & Will, 1976; Delasalle, Gesselin, Carayon, Legrand, Antreasian, Lagoguey, Legrand & Desgrez, 1977; Pratt, Holbrook, Dale & Melby, 1977; Kohl, Gless, Abdelhamid, Penke & Vecsei, 1978) and have not yet been sufficiently evaluated in comparison with aldosterone-18-glucuronide and free aldosterone.
We have determined the aldosterone and free aldosterone-1 8-glucuronide, tetrahydroaldosterone and free aldosterone simultaneously in patients with essential hypertension, primary hyperaldosteronism and with renal artery stenosis. There was serious disagreement between the three estimations in a group of patients. In the present paper, descriptions of these cases are given, and an attempt will be made to evaluate this discrepancy. In order to study liver and kidney function as a possible cause of the discrepancies between the methods used, data from patients with parenchymal kidney and liver diseases are also included.
Material and methods

Radioimmunoassay
Aldosterone-18-glucuronide, plasma aldosterone, tetrahydroaldosterone, urine free aldosterone and, in some of the cases, 18-hydroxycorticosterone, were determined by radioimmunoassay after extraction and chromatography. The technical details of these methods have been published elsewhere (Vecsei et al., 1972; Vecsei & Gless, 1975; Connolly, Vecsei, Haack, Abdelhamid & Ammenti, 1978; Kohl et al., 1978) .
Plasma renin activity was also determined by radioimmunoassay. The classification of hypertensive patients according to their plasma renin activities was carried out by the method of Brunner, Sealey & Laragh (1973) .
Patients
Patients referred to our department by general practitioners because of hypertension, were examined according to a standardized protocol, including extensive laboratory testing, intravenous urogram and a 1311-labelled Hippuran nephrogram. According to the results, the hypertensive patients were classified as having uncomplicated essential hypertension without elevation of plasma renin activity (n = 224), patients with essential hypertension and elevated plasma renin (n = 24) and those with renal artery stenosis (n = 11).
Antihypertensive therapy was withdrawn for at least 2 weeks (in the case of spironolactone, 6 weeks) before the investigations. All patients were on a free diet, but were instructed to limit their daily sodium intake to 120-140 mmollday.
Fifteen patients with primary hyperaldosteronism were divided into two subgroups: those w i t h adenoma confirmed by surgery (n = 5) and those who had not undergone surgery (n = 10). The latter subgroup consisted of two patients with adenoma visualized by X-ray examination of the adrenals, two patients in whom visualization of the adrenals had not yet been performed, and six patients classified as having bilaterial hyperplasia, according to adrenal phlebogrammes, scans and estimations of aldosterone and cortisol in adrenal vein blood samples.
Patients with renal parenchymal diseases were divided into two subgroups: those with (n = 19) and those without (n = 9) an elevation of blood pressure. Five patients with severe liver parenchymal diseases were also investigated.
Results
Control concentrations of the urinary free aldosterone ranged between 0.07 and 0.45 pug124 h, with a mean of 0.23 f 0.10 (n = 31). The tetrahydroaldosterone concentrations ranged between 10 and 70 pug124 h, with a mean of 32.58 f 17-13 (n = 33). Aldosterone-18-glucuronide concentrations were between 3.5 and 17.5 pgl24 h, with a mean of 8-03 f 3.59 (n = 59). The range of urinary 18-hydroxycorticosterone excretion was 1.5-6.5 pug124 h, with a mean of 4.08 2 1.44. The plasma renin activities (ng of angiotensin I h-' ml-I) were: normal subjects, supine 0.18-1.8 (mean 0.50), upright 0.4-3-6 (1.32); hypertension and low plasma renin activity, supine 0-05-0-3 (0.18), upright 0.1-0.45 (0.3); hypertension and normal plasma renin activity, supine 0.21-1 -4
Of 224 patients having essential hypertension without elevated plasma renin activity, 18 cases (8.4%) showed increased urine free aldosterone and/or tetrahydroaldosterone values without elevation of aldosterone-18-glucuronide. In eight patients, both free aldosterone and tetrahydroaldosterone values were increased, in four cases only free aldosterone, and in six cases only tetrahydroaldosterone (Table 1) .
In four patients, aldosterone-18-glucuronide excretion was found to be increased; in two cases with elevated free aldosterone. In some cases measurements of free urinary 18-hydroxycortico-(0-44), upright 0.55-3.7 (1.25). sterone were carried out, and Table 1 summarizes the results. Some 18-hydroxycorticosterone values were elevated and some remained in the normal range. Plasma renin activities were mostly in the low range. In 14 out of 23 patients with essential hypertension and high plasma renin activity, elevated aldosterone-18-glucuronide values with or without changes in the two other urinary aldosterone parameters were found (Table 2) .
In eight cases, an elevated excretion of free aldosterone or tetrahydroaldosterone was found without . pathological changes in aldosterone-18-glucuronide excretion.
In two out of 11 patients with renovascular hypertension, discrepancies in urinary aldosterone values were found (Table 3) .
This was also the case in five out of 19 hypertensive patients with renal parenchymal disease, in one out of ten without hypertension, and in three out of five with chronic liver parenchymal lesions.
Elevated free aldosterone and tetrahydroaldosterone excretions were found in all primary hyperaldosteronism patients; the aldosterone-18-glucuronide values were frequently within the normal range. The free 18-hydroxycorticosterone values were, at least temporarily, elevated or, in one case, close to the upper normal limit. No differences in steroid patterns between adenoma and suspected hyperplasia cases could be established.
Discussion
In 18 out of 224 patients (8.4%) with essential hypertension without elevated plasma renin, discrepancies between aldosterone-18-glucuronide, tetrahydroaldosterone and free aldosterone have been observed. The aldosterone-18-glucuronide values were found to be in the normal range, and tetrahydroaldosterone and/or free aldosterone were elevated (Table 1) . In several patients, in whom we have suspected aldosterone overproduction, one or both of tetrahydroaldosterone or free aldosterone excretions were elevated; other findings such as increased excretion of the supposed aldosterone precursor 18-hydroxycorticosterone supported our assumption of hyperaldosteronism.
When only one of the two parameters was elevated the patient may also have had hyperaldosteronism. However, abnormalities of aldosterone 
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R. (Deck & Siegenthaler, 1967) . Indeed, dissociations between the different aldosterone metabolites in patients with kidney diseases, support the possible role of this organ in the genesis of disturbances in aldosterone metabolism. As expected, in some patients with liver diseases the tetrahydroaldosterone values were found to be relatively low.
In other patients, variations of aldosterone metabolism may occur without pathological significance.
The individual variations in the formation of different aldosterone metabolites is supported by the observation that dissociations in urinary values were predominantly seen in patients with 18-glucuronide excretion of 10 pg/24 h or more (Table 1) .
Discrepancies were also found in two patients with primary hyperaldosteronism (Table 4 ). This observation is not unique in the literature. Wilson (1977) has reported a patient with primary hyperaldosteronism due to adrenal adenoma with normal aldosterone-18-glucuronide but elevated plasma aldosterone values. The same has been found by Vetter, Siebenschein, Studer, Witassek, Furrer, Gllinzer, Siegenthaler 8c Vetter (1978) , in eight cases with primary hyperaldosteronism.
The morphological classification of the patients with primary hyperaldosteronism, in whom surgery has not yet been performed, has to be evaluated with caution. Surgery on the primary hyperaldosteronism patients di. ' not always confirm the preoperative diagnosis.
The use of aldosterone-18-glucuronide as first choice for routine diagnosis in many laboratories is a long tradition. In the 1950s and 1960s the separation and measurement of aldosterone released by hydrolysis at pH 1 from aldosterone-18-glucuronide was a feasible method for many laboratories.
The data presented here, however, raise doubts as to the value of the sole use of this test. The determination of tetrahydroaldosterone and urinary free aldosterone seem to be more appropriate but none of the three urinary methods provides a certain diagnosis of hyperaldosteronism. Thus the use of three, or at least two (tetrahydroaldosterone and urine free aldosterone), determinations must be recommended as a superior diagnostic approach.
